Sign in to continue:

Saturday, March 7th, 2026

Advanced Systems Automation Limited FY2025 Results: No Dividend Declared Amid Net Loss and Segment Review

Advanced Systems Automation Limited: FY2025 Financial Review and Analysis

Advanced Systems Automation Limited (“ASA” or “the Group”) released its unaudited condensed consolidated financial statements for the full year ended 31 December 2025. The Group operates primarily in Equipment Contract Manufacturing Services (ECMS) and the Aquaculture segment, with its principal activities focused on precision engineering, fabrication, and aquaculture technology.

Key Financial Metrics

Metric 2H 2025 1H 2025 2H 2024 FY2025 FY2024 YoY Change (FY) QoQ Change (2H)
Revenue S\$7.9m S\$8.4m S\$8.5m S\$16.3m S\$17.1m -5% -7%
Gross Profit S\$0.5m S\$2.2m S\$2.0m S\$2.8m S\$4.5m -38% -73%
Net Loss After Tax S\$(14.9)m S\$(1.2)m S\$(5.6)m S\$(16.0)m S\$(6.1)m >100% >100%
EPS (Basic/Diluted) (0.88)c (0.06)c (0.75)c (0.94)c (0.82)c Negative Negative
Dividend None None None None None No Change No Change

Historical Performance Trends

The Group’s revenue declined for both the second half and full year 2025, driven primarily by a sharp drop in aquaculture segment sales—from S\$1.0 million in FY2024 to just S\$7,000 in FY2025, as major projects remained in the gestation phase. ECMS segment revenue remained relatively stable. Gross profit margins also fell substantially, reflecting higher raw material and operating costs, and lower capacity utilization at key business units. The net loss ballooned due to a significant impairment of goodwill (S\$14.1 million), recognized after the acquisition of LSO Organization Holdings Pte. Ltd.

Errors, Restatements, and Asset Revaluation

ASA restated its FY2024 financial statements following receipt of a final purchase price allocation report for the LSO acquisition. Key changes included a reduction in the fair value of consideration for LSO (from S\$20m to S\$13.16m), correcting the accounting for share-based fees, and revised impairment policies. The impairment of goodwill associated with LSO, and revised fair value for convertible notes (valued at their default redemption value post-maturity), had a material impact on FY2025 results.

Exceptional Expenses and Events

  • Impairment of Goodwill: S\$14.1 million impairment recorded in FY2025 following lower-than-expected performance from LSO and uncertainty on major aquaculture projects.
  • Legal Disputes: ASA faces ongoing litigation with ASTI Holdings Limited, which is claiming S\$9.9 million in loans and fees. The outcome is uncertain and pending mediation.
  • Irregularities Identified: The former CEO was involved in unauthorized alteration of bank signatories and issuance of cheques totaling S\$1.0 million. The matter is under investigation by authorities.
  • Debt-Equity Swap: ASA agreed to swap S\$2.0 million in matured convertible notes for new shares, pending shareholder approval. If all outstanding warrants are exercised, the company could raise S\$1.75 million in cash.
  • Potential Divestment: A conditional SPA was signed to dispose of LSO Organization Holdings Pte. Ltd. for up to S\$13m, subject to shareholder approval and other conditions.

Chairman’s Statement

“BY ORDER OF THE BOARD
Mr Chng Hee Kok
Independent Chairman
6 March 2026″

The tone of the Chairman’s statement is neutral, with no forward-looking optimism or pessimism explicitly stated.

Directors’ Pay/Remuneration

Accrued director fees for FY2025 amounted to S\$254,000, up from S\$150,000 in FY2024.

Share Capital Changes and Dilution

  • ASA issued new shares via conversion of warrants and rights issues, increasing the total share count to 1,665,144,000 at year end, and 1,705,144,341 by February 2026.
  • Outstanding warrants from rights issues could further dilute shareholders if exercised.
  • No share buybacks, but substantial dilution from equity issuances and debt-equity swaps.

Fund Flows, Related-Party Transactions, and Unusual Movements

  • Significant related-party transactions occurred, including deferred consideration payments, loans, and service fees with directors and substantial shareholders.
  • Cash and cash equivalents declined from S\$4.0m to S\$1.4m, reflecting negative cash flows from operations and investments.

Forecasted and Expected Events

  • The SPA for LSO’s disposal could materially improve ASA’s liquidity if completed.
  • Continued restructuring, attempted divestment, and potential capital raising indicate a defensive posture amid ongoing losses.
  • Management is actively seeking third-party funding, new bank facilities, and additional capital support.

Dividend Policy

No dividend has been declared or recommended for FY2025 or FY2024, due to accumulated losses.

Conclusion and Investment Recommendations

Overall Financial Performance: ASA’s FY2025 results are weak. The Group faces significant losses, declining revenue, sharp impairment of goodwill, ongoing legal disputes, and liquidity challenges. While ECMS remains profitable, the aquaculture segment underperformed and is subject to divestment. The company is actively restructuring, but uncertainty remains high.

Investor Recommendations

  • If you currently hold ASA shares: Consider reducing exposure or holding only if you are prepared for continued volatility and risk. The company is actively restructuring and may improve liquidity via asset sales, but ongoing losses, dilution, and legal disputes pose risks. Monitor developments closely.
  • If you do not hold ASA shares: Wait for further clarity on restructuring outcomes, divestment of LSO, and resolution of major legal and liquidity issues before considering entry. The current risk profile is high and the outlook is uncertain.

Disclaimer: This analysis is based strictly on the data and disclosures provided in the company’s official financial report for FY2025. It does not constitute financial advice. Investors should conduct their own research and consult professional advisers before making investment decisions.

View AdvancedSystems Historical chart here



Fu Yu Corporation Limited 1H2025 Results: Financial Performance, Segment Analysis & Outlook (SGX:S$FUYU)

Fu Yu Corporation Limited: 1H25 Financial Analysis & Outlook Fu Yu Corporation Limited, a Singapore-based precision plastics manufacturer, released its unaudited interim results for the six months ended 30 June 2025. The following analysis...

ESR-REIT Delivers 10.3% Rental Growth in FY2024; Strategic Acquisitions Set to Boost DPU in 2025

ESR-REIT: FY2024 Financial Analysis – Net Profit Decline by 4.2% ESR-REIT: FY2024 Financial Analysis – Net Profit Decline by 4.2% Overview Summary ESR-REIT, a leading Asia-Pacific real estate investment trust focused on New Economy...

ISEC Healthcare Ltd. 1H2025 Financial Results: Revenue Growth, Expansion Updates, and No Interim Dividend Declared

ISEC Healthcare Ltd. 1H2025 Financial Results: Solid Growth Amid Expansion and Strategic Investments ISEC Healthcare Ltd., a regional leader in medical eye care and general health services, has released its condensed interim financial statements...

   Ad